PET-CT and Circulating Tumor Cells in Colorectal Cancer

• Status: Completed
• Trial end date: 2017-04-27
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to identify an early indicator of drug efficacy in patients with advanced colorectal cancer - a prospective evaluation of circulating tumor cells, positron-emission tomography scan and RECIST criteria.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chinese University of Hong Kong

Criteria

Inclusion Criteria:

• Metastatic colorectal cancer patients not received prior drug treatment for metastatic CRC

• Age >= 18 years

• (ECOG) performance status of 0-2

• Measurable tumor sites by RECIST criteria

• Adequate bone marrow, renal & hepatic functions

Exclusion Criteria:

• Patients with diabetes mellitus

• presence of hyperglycemia

• Pregnant or lactating patients